180 related articles for article (PubMed ID: 8580277)
1. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
Laine L; Rabeneck L
Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.
Lake DE; Kunzweiler J; Beer M; Buell DN; Islam MZ
Chemotherapy; 1996; 42(4):308-14. PubMed ID: 8804799
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Barbaro G; Barbarini G; Di Lorenzo G
Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
De Wit S; Urbain D; Rahir F; Weerts D; Clumeck N
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):503-5. PubMed ID: 1915385
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Laing RB; Brettle RP; Leen CL
Int J STD AIDS; 1998 Jan; 9(1):16-20. PubMed ID: 9518009
[TBL] [Abstract][Full Text] [Related]
10. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
Mycoses; 1996; 39 Suppl 1():123-6. PubMed ID: 8767284
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Laine L; Dretler RH; Conteas CN; Tuazon C; Koster FM; Sattler F; Squires K; Islam MZ
Ann Intern Med; 1992 Oct; 117(8):655-60. PubMed ID: 1308663
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Di Lorenzo G
Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
[TBL] [Abstract][Full Text] [Related]
15. A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole.
Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
Mycoses; 1996; 39(9-10):357-60. PubMed ID: 9009658
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Krause DS; Simjee AE; van Rensburg C; Viljoen J; Walsh TJ; Goldstein BP; Wible M; Henkel T
Clin Infect Dis; 2004 Sep; 39(6):770-5. PubMed ID: 15472806
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
[TBL] [Abstract][Full Text] [Related]
18. Esophageal candidiasis in patients infected with the human immunodeficiency virus. A decision analysis to assess cost-effectiveness of alternative management strategies.
Rabeneck L; Laine L
Arch Intern Med; 1994 Dec 12-26; 154(23):2705-10. PubMed ID: 7993154
[TBL] [Abstract][Full Text] [Related]
19. Rationalizing prescribing for oral and oesophageal candidiasis.
Taylor CB; Finlay R; Richardson C; Bunting P; Welch J
Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678
[No Abstract] [Full Text] [Related]
20. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms.
Wilcox CM; Alexander LN; Clark WS; Thompson SE
Gastroenterology; 1996 Jun; 110(6):1803-9. PubMed ID: 8964406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
